Global Cord Blood Corp (CORBF)
OTCMKTS: CORBF · Delayed Price · USD
1.250
0.00 (0.00%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Global Cord Blood Market Cap

Global Cord Blood has a market cap or net worth of $167.39 million as of April 26, 2024. Its market cap has decreased by -69.93% in one year.

Market Cap
167.39M
Enterprise Value
-751.90M
1-Year Change
-69.93%
Ranking
n/a
Category
Stock Price
$1.25

Market Cap Chart

Since May 14, 2007, Global Cord Blood's market cap has decreased from $663.70M to $167.39M, a decrease of -74.78%. That is a compound annual growth rate of -8.57%.

History

DateMarket Cap% Change
Sep 26, 2022363.20M-
Sep 23, 2022363.20M34.62%
Sep 22, 2022269.80M-3.51%
Sep 21, 2022279.60M-2.95%
Sep 20, 2022288.10M-2.07%
Sep 19, 2022294.20M-0.41%
Sep 16, 2022295.40M-4.31%
Sep 15, 2022308.70M4.93%
Sep 14, 2022294.20M3.88%
Sep 13, 2022283.20M1.29%
Sep 12, 2022279.60M3.63%
Sep 9, 2022269.80M-
Sep 8, 2022269.80M0.45%
Sep 7, 2022268.60M-1.79%
Sep 6, 2022273.50M-2.60%
Sep 2, 2022280.80M-0.43%
Sep 1, 2022282.00M0.43%
Aug 31, 2022280.80M5.96%
Aug 30, 2022265.00M0.91%
Aug 29, 2022262.60M-6.08%
Aug 26, 2022279.60M3.63%
Aug 25, 2022269.80M-6.74%
Aug 24, 2022289.30M-0.82%
Aug 23, 2022291.70M1.67%
Aug 22, 2022286.90M0.88%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 697.40B
Novo Nordisk 550.22B
UnitedHealth Group 455.76B
Johnson & Johnson 352.17B
Merck & Co. 332.28B
AbbVie 282.63B
AstraZeneca 233.01B
Thermo Fisher 218.95B
Market Cap Rankings